DEFA14A: BlackRock Health Sciences Term Trust Faces Activist Challenge from Saba Capital

BlackRock Health Sciences Term Trust (BMEZ) urges shareholders to vote against Saba Capital's proposal to replace the investment advisor and board members at the upcoming annual meeting.

Summary

• BlackRock Health Sciences Term Trust (BMEZ) is facing a challenge from activist hedge fund Saba Capital Management L.P.
• Saba is attempting to replace BlackRock as the fund's investment advisor and install its own board members.
• BlackRock is urging shareholders to vote FOR BlackRock's board nominees and AGAINST Saba's proposal at the Annual Meeting on June 25.
• BlackRock highlights BMEZ's outperformance, including a 14% return on market price year-to-date in 2024, outperforming 93% of all closed-end funds, and a 5.1% return on market price in 2023, outperforming 100% of peer funds.
• The fund offers a 6.6% yield on market price and has voluntarily repurchased over $95 million of shares since inception, adding approximately $18 million to BMEZ's net asset value.
• The fund has adopted a managed distribution plan to support a distribution of income, capital gains and/or return of capital based on an annual rate of 6% of the Funds 12-month rolling average daily net asset value.
• The fund estimates that it has distributed more than its income and net-realized capital gains in the current fiscal year; therefore, a portion of your distribution may be a return of capital.

Sentiment

Score: 7

Explanation: The document presents a generally positive view of the fund's performance and management, while acknowledging the challenge from an activist investor. The tone is defensive, aiming to reassure shareholders and encourage them to support the existing board.

Positives

• BMEZ has demonstrated strong performance relative to its peers.
• The fund offers a high yield compared to health care companies.
• Share repurchases have increased the fund's net asset value.
• The fund has a managed distribution plan to provide consistent income to shareholders.
• The fund's management team has extensive experience in healthcare investing.

Negatives

• A portion of the fund's distributions may be a return of capital, which does not necessarily reflect investment performance.
• The fund is facing a challenge from an activist hedge fund, creating uncertainty about its future strategy.

Risks

• Saba Capital's attempt to replace the investment advisor and board members could lead to changes in the fund's strategy and performance.
• Market conditions can cause fluctuations in the fund's dividend yield, market price, and net asset value.
• Distributions may include return of capital, which can reduce the fund's net asset value per share.

Future Outlook

The document focuses on the upcoming shareholder vote and does not provide specific forward-looking statements about the fund's future performance, other than to say that the future of your long-term investment depends on you.

Management Comments

• BlackRock is urging shareholders to vote FOR BlackRock's board nominees and AGAINST Saba's proposal to protect their investment.
• BlackRock emphasizes the experience and expertise of its management team, led by Dr. Erin Xie.

Industry Context

The document highlights the increasing trend of activist investors targeting closed-end funds to influence management and strategy.

Comparison to Industry Standards

• The document compares BMEZ's performance to the Morningstar Closed-End Health category.
• The document compares BMEZ's dividend yield to the MSCI ACWI Health Care Index.
• The document does not provide specific comparisons to individual companies or projects.

Stakeholder Impact

• The outcome of the shareholder vote will impact the fund's strategy and management, affecting shareholders.
• Changes to the investment advisor could affect the fund's performance and distributions, impacting shareholder returns.

Next Steps

• Shareholders are urged to vote on the enclosed white proxy card before the Annual Meeting on June 25.
• Shareholders can vote online, by phone, or by mail.

Key Dates

Keywords

BlackRock Health Sciences Term Trust, BMEZ, Saba Capital, activist hedge fund, proxy fight, investment advisor, board nominees, closed-end fund, health sciences, distributions, share repurchase, managed distribution plan